These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 38286559)
21. Yttrium Oxide nanoparticles induce cytotoxicity, genotoxicity, apoptosis, and ferroptosis in the human triple-negative breast cancer MDA-MB-231 cells. Emad B; WalyEldeen AA; Hassan H; Sharaky M; Abdelhamid IA; Ibrahim SA; Mohamed HR BMC Cancer; 2023 Nov; 23(1):1151. PubMed ID: 38012585 [TBL] [Abstract][Full Text] [Related]
22. Hyaluronic acid-capped compact silica-supported mesoporous titania nanoparticles for ligand-directed delivery of doxorubicin. Gupta B; Poudel BK; Ruttala HB; Regmi S; Pathak S; Gautam M; Jin SG; Jeong JH; Choi HG; Ku SK; Yong CS; Kim JO Acta Biomater; 2018 Oct; 80():364-377. PubMed ID: 30201431 [TBL] [Abstract][Full Text] [Related]
23. Tumor Cell Targeting and Responsive Nanoplatform for Multimodal-Imaging Guided Chemodynamic/Photodynamic/Photothermal Therapy toward Triple Negative Breast Cancer. Li L; Li J; Hu R; Zhang X; Ding L; Ren G; Liu W; Wang H; Wang B; Zhang C; Diao H ACS Appl Mater Interfaces; 2023 Jun; 15(23):27706-27718. PubMed ID: 37261936 [TBL] [Abstract][Full Text] [Related]
24. Identification of a small molecule as inducer of ferroptosis and apoptosis through ubiquitination of GPX4 in triple negative breast cancer cells. Ding Y; Chen X; Liu C; Ge W; Wang Q; Hao X; Wang M; Chen Y; Zhang Q J Hematol Oncol; 2021 Jan; 14(1):19. PubMed ID: 33472669 [TBL] [Abstract][Full Text] [Related]
25. Hyaluronic acid coated mesoporous carbon-copper peroxide for H Xin Z; Shen Y; Hao H; Zhang L; Hu X; Wang J Colloids Surf B Biointerfaces; 2022 Oct; 218():112776. PubMed ID: 36007311 [TBL] [Abstract][Full Text] [Related]
26. A Novel Derivative of Curcumol, HCL-23, Inhibits the Malignant Phenotype of Triple-Negative Breast Cancer and Induces Apoptosis and HO-1-Dependent Ferroptosis. Zhao P; Song H; Gao F; Chen L; Qiu J; Jin J; Pan C; Tang Y; Chen M; Pan Y; Li Y; Huang L; Yang J; Hao X Molecules; 2023 Apr; 28(8):. PubMed ID: 37110625 [TBL] [Abstract][Full Text] [Related]
27. Cholecalciferol-PEG Conjugate Based Nanomicelles of Doxorubicin for Treatment of Triple-Negative Breast Cancer. Kutlehria S; Behl G; Patel K; Doddapaneni R; Vhora I; Chowdhury N; Bagde A; Singh M AAPS PharmSciTech; 2018 Feb; 19(2):792-802. PubMed ID: 29019073 [TBL] [Abstract][Full Text] [Related]
28. Efficient Magnetic Nanocatalyst-Induced Chemo- and Ferroptosis Synergistic Cancer Therapy in Combination with T Zhu L; Wang J; Tang X; Zhang C; Wang P; Wu L; Gao W; Ding W; Zhang G; Tao X ACS Appl Mater Interfaces; 2022 Jan; 14(3):3621-3632. PubMed ID: 35005898 [TBL] [Abstract][Full Text] [Related]
29. Nitric oxide nano-reactor DNMF/PLGA enables tumor vascular microenvironment and chemo-hyperthermia synergetic therapy. Wang R; Cheng L; He L; Du C; Wang H; Peng B; Yu X; Liu W; Luo W; Ran H; Yang L J Nanobiotechnology; 2024 Mar; 22(1):110. PubMed ID: 38481281 [TBL] [Abstract][Full Text] [Related]
30. Doxorubicin-Hyaluronan Conjugated Super-Paramagnetic Iron Oxide Nanoparticles (DOX-HA-SPION) Enhanced Cytoplasmic Uptake of Doxorubicin and Modulated Apoptosis, IL-6 Release and NF-kappaB Activity in Human MDA-MB-231 Breast Cancer Cells. Vyas D; Lopez-Hisijos N; Gandhi S; El-Dakdouki M; Basson MD; Walsh MF; Huang X; Vyas AK; Chaturvedi LS J Nanosci Nanotechnol; 2015 Sep; 15(9):6413-22. PubMed ID: 26690867 [TBL] [Abstract][Full Text] [Related]
31. Co-delivery of gambogic acid and TRAIL plasmid by hyaluronic acid grafted PEI-PLGA nanoparticles for the treatment of triple negative breast cancer. Wang S; Shao M; Zhong Z; Wang A; Cao J; Lu Y; Wang Y; Zhang J Drug Deliv; 2017 Nov; 24(1):1791-1800. PubMed ID: 29172759 [TBL] [Abstract][Full Text] [Related]
32. Shuganning injection, a traditional Chinese patent medicine, induces ferroptosis and suppresses tumor growth in triple-negative breast cancer cells. Du J; Wang L; Huang X; Zhang N; Long Z; Yang Y; Zhong F; Zheng B; Lan W; Lin W; Ma W Phytomedicine; 2021 May; 85():153551. PubMed ID: 33827043 [TBL] [Abstract][Full Text] [Related]
33. Polypyrrole-based nanotheranostics for activatable fluorescence imaging and chemo/photothermal dual therapy of triple-negative breast cancer. Park D; Ahn KO; Jeong KC; Choi Y Nanotechnology; 2016 May; 27(18):185102. PubMed ID: 27004751 [TBL] [Abstract][Full Text] [Related]
34. Delivery of mitochondriotropic doxorubicin derivatives using self-assembling hyaluronic acid nanocarriers in doxorubicin-resistant breast cancer. Liu HN; Guo NN; Guo WW; Huang-Fu MY; Vakili MR; Chen JJ; Xu WH; Wei QC; Han M; Lavasanifar A; Gao JQ Acta Pharmacol Sin; 2018 Oct; 39(10):1681-1692. PubMed ID: 29849132 [TBL] [Abstract][Full Text] [Related]
35. A copper nanocluster-based multifunctional nanoplatform for augmented chemo/chemodynamic/photodynamic combination therapy of breast cancer. Zhang J; Li P; Wang T; Li J; Yun K; Zhang X; Yang X Pharmacol Res; 2023 Jan; 187():106632. PubMed ID: 36572134 [TBL] [Abstract][Full Text] [Related]
36. Novel Withanolides from Huang L; Wei Y; Ni M; Hu H; Xi L; Wang C; Zhu Z; Yang B; Zhao H Molecules; 2024 Apr; 29(8):. PubMed ID: 38675657 [TBL] [Abstract][Full Text] [Related]
37. Copper-Based Composites Nanoparticles Improve Triple-Negative Breast Cancer Treatment with Induction of Apoptosis-Cuproptosis and Immune Activation. Wang N; Liu Y; Peng D; Zhang Q; Zhang Z; Xu L; Yin L; Zhao X; Lu Z; Peng J Adv Healthc Mater; 2024 Nov; 13(28):e2401646. PubMed ID: 39001628 [TBL] [Abstract][Full Text] [Related]
38. Targeted polymeric nanoparticles for drug delivery to hypoxic, triple-negative breast tumors. Mamnoon B; Loganathan J; Confeld MI; De Fonseka N; Feng L; Froberg J; Choi Y; Tuvin DM; Sathish V; Mallik S ACS Appl Bio Mater; 2021 Feb; 4(2):1450-1460. PubMed ID: 33954285 [TBL] [Abstract][Full Text] [Related]
39. Multifunctional Nanoplatform-Mediated Chemo-Photothermal Therapy Combines Immunogenic Cell Death with Checkpoint Blockade to Combat Triple-Negative Breast Cancer and Distant Metastasis. Zhu H; Yang K; Yao H; Chen X; Yan S; He Y; Cao Y; Luo J; Wang D Int J Nanomedicine; 2023; 18():3109-3124. PubMed ID: 37323948 [TBL] [Abstract][Full Text] [Related]
40. Repurposing suramin for the treatment of breast cancer lung metastasis with glycol chitosan-based nanoparticles. Cheng B; Gao F; Maissy E; Xu P Acta Biomater; 2019 Jan; 84():378-390. PubMed ID: 30528604 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]